Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 29 for

Edit search filters
  1. A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care versus Standard of Care Alone in the Treatment of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome in Patients post Double Lung Transplantation (BOSTON-2)

    Jacksonville, FL

  2. Health Coaching to Improve Self-Management in Thoracic Transplant Candidates

    Rochester, MN

  3. A Study to Evaluate the Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes Following Lung Transplant

    Jacksonville, FL

  4. Mesenchymal Stem Cell Therapy for Lung Rejection

  5. Heart Failure and Cardiothoracic Transplant Biorepository

    Rochester, MN

  6. A Study to Evaluate Clinical Performance of the Aptima® CMV Quant Assay on the Panther® System

    Rochester, MN

  7. A Study to Analyze Lung Transplant Recipients’ Perspective on Antifungal Prophylaxis

    Rochester, MN, Jacksonville, FL

  8. Caregiver Registry

    Rochester, MN

  9. Cardio-Pulmonary Bypass Versus Extracorporeal Membrane Oxygenation as an Independent Risk Factor for Development of Primary Graft Dysfunction Post Lung Transplant

    Jacksonville, FL

  10. Study Analyzing Effectiveness of BIomarker for Immunosuppression Following Induction Immunosuppression for Lung Transplantation.

    Jacksonville, FL

.

Mayo Clinic Footer